COVID-19 vaccines are nearing the finish line with Moderna and Pfizer, but the race is far from over
Many hurdles must be overcome before the COVID-19 vaccine is available for widespread use and before we’re officially out of the woods with the pandemic, says Nada Sanders, distinguished professor of supply chain management at Northeastern.